{"gene":"PLAG1","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":2000,"finding":"PLAG1 is a nuclear protein that binds DNA in a sequence-specific manner via a bipartite consensus sequence (GRGGC core + RGGK G-cluster separated by 7 random nucleotides); DNA binding is mediated mainly by zinc fingers 3, 6, and 7. PLAG1 activates transcription from this consensus site and directly binds the IGF-II P3 promoter, stimulating IGF-II expression.","method":"DNA binding assays, transient transactivation assays, zinc finger mutagenesis, promoter binding studies","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro DNA-binding assays with mutagenesis of individual zinc fingers, transactivation reporter assays, and promoter binding experiments, all in a single rigorous study","pmids":["10646861"],"is_preprint":false},{"year":1999,"finding":"PLAG1 is activated in pleomorphic adenomas by promoter swapping with constitutively expressed partner genes (CTNNB1/beta-catenin, TCEA1/SII), where fusions in the 5' noncoding region exchange regulatory elements and drive ectopic PLAG1 expression. This mechanism operates even in tumors with grossly normal karyotypes via cryptic rearrangements.","method":"Northern blot, RNase protection, 5'-RACE, RT-PCR, nucleotide sequencing","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — replicated across multiple labs and tumor types; multiple orthogonal molecular methods (RACE, RT-PCR, sequencing) identifying fusion transcripts","pmids":["10029085"],"is_preprint":false},{"year":2000,"finding":"PLAG1 is activated in lipoblastoma via promoter-swapping events fusing the HAS2 or COL1A2 gene promoter to the PLAG1 coding sequence, driving ectopic PLAG1 overexpression in a non-epithelial tumor context.","method":"Cytogenetics, RT-PCR, promoter fusion analysis","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple independent lipoblastoma cases, replicated by several subsequent studies confirming the same promoter-swapping mechanism","pmids":["10987300"],"is_preprint":false},{"year":2002,"finding":"PLAG1 is imported into the nucleus via interaction with karyopherin alpha2 (importin-alpha2). The NLS1 sequence (KRKR) in PLAG1 is essential for physical interaction with karyopherin alpha2 and for nuclear import; the zinc finger domain also contributes to residual nuclear import independently of NLS1.","method":"Yeast two-hybrid, GST pull-down assay, NLS mutagenesis, nuclear import assay with beta-galactosidase reporter","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution with GST pull-down, mutagenesis of NLS, and functional nuclear import assays in a single study","pmids":["11882654"],"is_preprint":false},{"year":2004,"finding":"PLAG1 transactivating capacity is repressed by SUMOylation at Lys-244 and Lys-263. Mutation of both SUMO consensus sites inhibits SUMOylation and significantly increases PLAG1 transactivation; SUMO-1-modified forms of PLAG1 (single and double) were detected endogenously.","method":"In vivo SUMOylation assay, site-directed mutagenesis of SUMO consensus sites, transactivation reporter assays, anti-PLAG1 immunoblot","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis of specific lysines combined with in vivo SUMOylation assay and functional transactivation readout in one rigorous study","pmids":["15208321"],"is_preprint":false},{"year":2005,"finding":"PLAG1 is regulated by both SUMOylation (repressive) and acetylation (activating). PLAG1 is acetylated and activated by p300 and deacetylated and repressed by HDAC7. A conserved transcriptional repression domain depends on three sumoylation motifs; sumoylation at Lys-244, Lys-263, and Lys-353 inhibits PLAG1-induced IGF-II expression. Sumoylation-deficient PLAG1 localizes to the nucleolus rather than the nucleus. Mutation of the three sumoylation-site lysines significantly impairs PLAG1 transformation ability.","method":"In vivo sumoylation assay, acetylation assay with p300/HDAC7 overexpression, reporter assays, subcellular localization, transformation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal methods (sumoylation, acetylation, localization, transformation) in one study, with site-specific mutagenesis","pmids":["16207715"],"is_preprint":false},{"year":2004,"finding":"PLAG1 microarray analysis identified 47 induced and 12 repressed target genes upon conditional induction in fetal kidney 293 cells. Major upregulated targets include IGF-II and cytokine-like factor 1; the consensus PLAG1 binding motif GRGGC(N)6-8GGG was enriched in promoters of upregulated genes. Concordance with pleomorphic adenoma expression profiles identified 12 consistent PLAG1 target genes.","method":"Oligonucleotide microarray of ~12,000 genes in conditional PLAG1 expression cell lines, in silico promoter analysis","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-scale expression profiling with conditional induction, validated by comparison with tumor expression data, single lab","pmids":["14712223"],"is_preprint":false},{"year":2004,"finding":"Plag1 and Plagl2 independently cooperate with CBFbeta-SMMHC in vivo to induce acute myeloid leukemia with short latency in mice. Plag1 promotes G1-to-S phase transition and expands hematopoietic progenitors in vitro.","method":"In vivo mouse leukemia model, in vitro proliferation and cell cycle assays","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo mouse leukemia model with defined genetic cooperation and in vitro cell cycle phenotype, replicated with multiple mouse cohorts","pmids":["15585652"],"is_preprint":false},{"year":2004,"finding":"Targeted disruption of murine Plag1 causes postnatal growth retardation and reduced fertility in both male and female mice. Plag1-/- mice have proportionally smaller organs except for disproportionally small seminal vesicles and ventral prostate. Igf2 expression is not affected in Plag1-/- embryos, suggesting Plag1 regulates postnatal growth through Igf2-independent mechanisms as well.","method":"Targeted gene disruption, growth measurement, organ weight analysis, Northern blot for Igf2","journal":"Development, growth & differentiation","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic KO with defined phenotypic readouts, confirmed negative Igf2 result adds mechanistic specificity","pmids":["15606491"],"is_preprint":false},{"year":2005,"finding":"Conditional PLAG1 overexpression in salivary and mammary glands of transgenic mice induces pleomorphic adenomas with upregulation of the Igf2/H19 and Dlk1/Gtl2 imprinted gene clusters, establishing a direct in vivo tumorigenic role for PLAG1.","method":"Cre/loxP conditional transgenic mouse model, histopathology, gene expression analysis","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — two independent founder strains, 100% tumor penetrance in one line, in vivo target gene expression validated","pmids":["15930271"],"is_preprint":false},{"year":2004,"finding":"PLAG1 transactivates transcription from the embryonic IGF2 P3 promoter in hepatoblastoma cell lines, as demonstrated by luciferase reporter assays, linking PLAG1 overexpression to IGF2 upregulation in hepatoblastoma.","method":"Luciferase reporter assay in hepatoblastoma cell lines, real-time RT-PCR","journal":"Genes, chromosomes & cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional transactivation assay in cell lines, supported by expression correlation, single lab","pmids":["14695992"],"is_preprint":false},{"year":2006,"finding":"CHCHD7-PLAG1 is a recurrent gene fusion in pleomorphic adenomas generated by a cryptic intrachromosomal 8q rearrangement, where CHCHD7 (located head-to-head ~500 bp from PLAG1) provides its promoter to drive PLAG1 expression by promoter swapping. PLAG1 protein is overexpressed in epithelial, myoepithelial, and mesenchymal-like tumor cells in these tumors.","method":"Cytogenetics, molecular analysis, Northern blot, Western blot, immunohistochemistry, FISH on nuclear chromatin fibers","journal":"Genes, chromosomes & cancer","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (cytogenetics, molecular analysis, protein expression) confirming fusion and promoter-swapping mechanism","pmids":["16736500"],"is_preprint":false},{"year":2006,"finding":"PLAG1 activates transcription of mouse (but not human) beta-catenin; four PLAG1 consensus binding sites are present in the mouse beta-catenin promoter but not in human. In PLAG1 transgenic mouse tumors, beta-catenin and downstream Wnt target c-myc are upregulated at the transcriptional level.","method":"Cotransfection reporter assay in 3T3 cells, promoter sequence analysis, immunohistochemistry","journal":"International journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assay with sequence analysis, supported by in vivo IHC in transgenic model, single lab","pmids":["16108035"],"is_preprint":false},{"year":2008,"finding":"Inactivation of Igf2 in PLAG1-transgenic mice (P1-MCre) significantly delays salivary gland tumor development but does not fully abrogate it; Wnt signaling genes (Wnt6, Cyclin D1, beta-catenin), H19, Dlk1, Gtl2, Igfbp2, and Igfbp3 are upregulated in the Igf2-inactivated PLAG1 tumors, indicating both IGF and Wnt signaling contribute to PLAG1-induced tumorigenesis.","method":"Genetic epistasis in conditional transgenic mice (Igf2 inactivation on PLAG1-OE background), tumor latency measurement, gene expression analysis","journal":"International journal of oncology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic epistasis experiment in vivo with defined phenotypic readout (tumor latency) and target gene expression validation","pmids":["18425330"],"is_preprint":false},{"year":2007,"finding":"FGFR1-PLAG1 fusion genes are generated by ring chromosome formation from chromosome 8; the 5' part of FGFR1 (8p12) is linked to the PLAG1 coding sequence (8q12.1), providing an active promoter to drive PLAG1 expression.","method":"SKY, FISH, high-resolution oligonucleotide array-CGH, molecular analysis","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple genomic methods confirming fusion gene structure, single lab","pmids":["18059337"],"is_preprint":false},{"year":2009,"finding":"PLAG1 protein expression is elevated in CLL cells compared to normal B cells due to translational derepression, caused by epigenetic silencing (methylation) of miR-181a, miR-181b, miR-107, and miR-424. Luciferase reporter assays with site-directed mutagenesis of the PLAG1 3'UTR confirmed direct regulation of PLAG1 by these miRNAs. PLAG1 mRNA levels were not affected, demonstrating post-transcriptional regulation.","method":"miRNA expression profiling, luciferase reporter assays with site-directed mutagenesis of 3'UTR binding sites, Western blot, methylation analysis of miRNA promoters","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1 / Moderate — luciferase reporter with mutagenesis of specific binding sites plus Western blot protein quantification, demonstrating post-transcriptional mechanism","pmids":["19692702"],"is_preprint":false},{"year":2012,"finding":"PLAG1 binding to the IGF2 P3 promoter is cell type-specific; ChIP shows PLAG1 binding in Hep3B but not JEG-3 cells at the endogenous locus. The H19 chromatin insulator modulates PLAG1 responsiveness in a cell type-dependent manner. PLAG1 induction partially overrides insulator function in reporter systems but does not consistently activate the endogenous IGF2 gene in JEG-3 cells.","method":"Chromatin immunoprecipitation (ChIP), GFP reporter/insulator assay, FACS analysis of stable inducible PLAG1 cell clones","journal":"International journal of oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and functional reporter assays, but conclusions limited to two cell lines and endogenous locus was partially refractory","pmids":["23023303"],"is_preprint":false},{"year":2017,"finding":"PLAG1 upregulates GDH1 (glutamate dehydrogenase 1) expression upon cell detachment, providing anti-anoikis signals in LKB1-deficient lung cancer. The GDH1 product alpha-KG activates CamKK2 by enhancing its substrate AMPK binding, promoting energy production conferring anoikis resistance. This establishes a PLAG1-GDH1-alpha-KG-CamKK2-AMPK axis.","method":"Genetic knockdown/overexpression, biochemical assays, patient-derived xenograft model, co-immunoprecipitation","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — mechanistic pathway placement via multiple orthogonal experiments including KD, co-IP, metabolic assays, and in vivo PDX validation","pmids":["29249655"],"is_preprint":false},{"year":2017,"finding":"Functional experiments demonstrate that HMGA2 regulates IGF2 expression through PLAG1, establishing a HMGA2-PLAG1-IGF2 regulatory pathway. Loss-of-function mutations in PLAG1 in humans cause Silver-Russell syndrome with fetal growth restriction. HMGA2 also regulates IGF2 in a PLAG1-independent manner.","method":"Whole-exome sequencing, targeted sequencing, functional experiments linking genes in the pathway","journal":"Genetics in medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — human loss-of-function mutations identified and functionally validated in a pathway context, replicated across multiple families","pmids":["28796236"],"is_preprint":false},{"year":2014,"finding":"HMGA2 overexpression in MCF-7 cells induces increased PLAG1 mRNA expression within 24–48 hours, and stimulation of HMGA2 by FGF1 in adipose-derived stem cells simultaneously increases PLAG1 mRNA. In leiomyomas with HMGA2 overexpression but no chromosome 8 abnormalities, PLAG1 is consistently activated, suggesting HMGA2 is an upstream transcriptional activator of PLAG1.","method":"Transient transfection of HMGA2 in MCF-7 cells, FGF1 stimulation assay, quantitative RT-PCR","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — transient transfection with mRNA quantification, supported by human tumor correlations, single lab","pmids":["24516594"],"is_preprint":false},{"year":2017,"finding":"PLAG1 deficiency in male mice results in significantly reduced daily sperm production, reduced sperm motility, and sloughing of the germinal epithelium. PLAG1 is expressed in germ cells and Sertoli cells. Genes involved in spermatogenesis and Hsd17b3 (androgen biosynthesis) are downregulated in Plag1 knockout testes.","method":"Plag1 knockout mouse analysis, X-gal staining for localization, RNA-seq, testicular histology, sperm motility assays","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with multiple quantitative phenotypic readouts (sperm production, motility) and genome-wide expression profiling to identify downstream target genes","pmids":["28706261"],"is_preprint":false},{"year":2018,"finding":"PLAG1 and USF2 co-occupy the MSI2 promoter in human hematopoietic stem and progenitor cells (HSPCs) and cooperate to transactivate endogenous MSI2. Coincident overexpression of PLAG1 and USF2 in cord blood progenitors enhances MSI2 transcription and expands CD34+ cells in vitro. ChIP-seq confirms co-binding of PLAG1 and USF2 at the MSI2 promoter and other HSPC regulatory loci.","method":"ChIP-seq, luciferase reporter assays, PLAG1/USF2 overexpression in cord blood cells, FACS for CD34+ expansion","journal":"Stem cell reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP-seq with functional validation (reporter assay and cellular phenotype), multiple orthogonal methods in one study","pmids":["29641991"],"is_preprint":false},{"year":2018,"finding":"PLAG1 is a microRNA target gene derepressed by mutations in microRNA biogenesis machinery in Wilms tumors. PLAG1 overexpression accelerates Wilms tumor cell growth in vitro and induces neoplastic growth in the developing mouse kidney in vivo by transactivating IGF2 and driving mTORC1 signaling.","method":"In vitro cell growth assays, in vivo mouse kidney injection model, luciferase reporter for IGF2 transactivation, pathway analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vitro and in vivo functional models with mechanistic pathway placement (PLAG1→IGF2→mTORC1), single lab with multiple orthogonal approaches","pmids":["30026293"],"is_preprint":false},{"year":2016,"finding":"PLAG1 as a transcription factor reinforces BCL2 promoter activity, upregulating BCL2 mRNA; knockdown of PLAG1 reduces BCL2 expression and sensitizes AML cells to TRAIL-induced apoptosis and proliferation inhibition. Restoration of BCL2 eliminates the sensitizing effects of PLAG1 knockdown.","method":"BCL2 promoter luciferase reporter assay, PLAG1 siRNA knockdown, apoptosis and proliferation assays, BCL2 restoration rescue experiment","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assay for BCL2 promoter plus KD phenotype with rescue, single lab","pmids":["27013583"],"is_preprint":false},{"year":2022,"finding":"PLAG1 is essential for long-term human HSC function and promotes HSC self-renewal by dampening protein synthesis. Genome-wide ChIP occupancy and gene expression analysis show PLAG1 restrains translation via upregulating 4EBP1 and translation-targeting miR-127, independently of stress response signaling. The advantages conferred by PLAG1 are attenuated by c-MYC overexpression.","method":"Genome-wide chromatin occupancy (ChIP-seq), RNA-seq, functional HSC assays, in vitro protein synthesis measurement, genetic epistasis with c-MYC","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide occupancy data combined with functional HSC assays and mechanistic epistasis (PLAG1 vs. c-MYC), multiple orthogonal methods in one study","pmids":["35639948"],"is_preprint":false},{"year":2020,"finding":"PLAG1 promotes proliferation and inhibits apoptosis in bovine primary myoblasts by upregulating phosphorylated PI3K/Akt, Cyclin D1, and CDK2 (via ChIP-seq evidence) and upregulating Bcl-2/Bcl-xL while inhibiting p21/p27. PLAG1 is a direct target of miR-1, which negatively regulates PLAG1 expression.","method":"CCK-8 assay, EdU proliferation assay, ChIP-seq, flow cytometry, Western blot, dual-luciferase assay for miR-1 targeting","journal":"Journal of animal science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-seq combined with functional assays and validated miR-1 targeting by luciferase assay, single lab in bovine model","pmids":["35325183"],"is_preprint":false},{"year":2020,"finding":"PLAG1 silencing in ovarian cancer cells decreases expression of IGF2, IGF1 receptor, and IRS1, and inhibits cell proliferation, migration, invasion, and cisplatin resistance in an IGF2-dependent manner.","method":"siRNA knockdown, pcDNA overexpression, cell proliferation/migration/invasion assays, Western blot","journal":"International journal of molecular medicine","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — siRNA KD with functional phenotype and IGF2-dependence rescue, single lab","pmids":["31922228"],"is_preprint":false},{"year":2018,"finding":"PLAG1 promotes proliferation and survival of rhabdomyosarcoma cells by inducing IGF2 expression and activating AKT and MAPK pathways. IGF2 partially rescues cell death triggered by PLAG1 knockdown. PLAG1 expression level correlates with sensitivity to IGF receptor inhibitor BMS754807.","method":"PLAG1 knockdown and ectopic overexpression, xenograft model, pathway activation assays (AKT/MAPK), IGF2 rescue experiment","journal":"Molecular cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KD/OE with in vivo xenograft and pathway analysis, including rescue experiment confirming IGF2 dependence, single lab","pmids":["31757836"],"is_preprint":false},{"year":2024,"finding":"PLAG1 confers resistance to sorafenib-induced ferroptosis in HCC by transcriptionally driving expression of GPX4 (glutathione peroxidase 4), thereby reducing lipid peroxidation. Sorafenib decreases PLAG1 at the transcriptional level through its upstream lncRNA PVT1. ChIP assay confirmed PLAG1 binding to the GPX4 promoter; PLAG1 and GPX4 protein levels are positively correlated in HCC patients.","method":"ChIP assay, luciferase reporter assay, ubiquitination assay, RNA immunoprecipitation (RIP) assay, CRISPR screening, tissue microarrays","journal":"Journal of experimental & clinical cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assay establishing PLAG1→GPX4 transcriptional axis, supported by patient tissue data, single lab","pmids":["38745179"],"is_preprint":false},{"year":2018,"finding":"In Wilms tumors, PLAG1 promoter occupancy by ChIP-seq analysis and MSI2 co-regulation experiments establish that PLAG1 directly activates MSI2 transcription in HSPCs alongside USF2.","method":"ChIP-seq","journal":"Stem cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-seq confirmation of co-binding, single lab","pmids":["29641991"],"is_preprint":false},{"year":2018,"finding":"Plag1 mutant neocortical progenitors proliferate less and produce more neurons at E12.5, while Plag1 gain-of-function reduces neurogenesis and increases BrdU uptake (enhanced proliferation). Plag1 and Plagl2 double-mutants are embryonic lethal, indicating at least one copy of either gene is required for embryonic survival.","method":"Single and double mutant mouse analysis, BrdU labeling, neurogenesis quantification in neocortex","journal":"Biology open","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO and overexpression in vivo with quantitative cellular phenotype, single lab","pmids":["30361413"],"is_preprint":false},{"year":2008,"finding":"Furin (proprotein convertase) facilitates PLAG1-induced salivary gland tumorigenesis; genetic ablation of fur with PLAG1 overexpression significantly delays tumor onset, and fur inactivation alone causes smaller but histologically normal salivary glands.","method":"MMTV-Cre genetic epistasis in mice (fur KO on PLAG1 transgenic background), histopathology, tumor latency measurement","journal":"International journal of oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in vivo showing furin cooperates with PLAG1, single lab","pmids":["18425334"],"is_preprint":false},{"year":2020,"finding":"PLAG1 acts as a transcriptional activator of PLIN1 (perilipin 1) in bovine adipocytes. EMSA and siRNA interference confirmed PLAG1 binding to its consensus site in the PLIN1 core promoter (-209/-17 bp), and PLAG1 knockdown reduced PLIN1-driven luciferase activity and impaired lipid metabolism in adipocytes.","method":"Promoter cloning and luciferase assay, EMSA, siRNA knockdown, mutational analysis of promoter fragments","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA and functional luciferase assay with siRNA KD, single lab in bovine model","pmids":["31981700"],"is_preprint":false}],"current_model":"PLAG1 is a developmentally regulated C2H2 zinc finger transcription factor that binds a bipartite DNA consensus sequence (GRGGC[N6–8]GGG) via zinc fingers 3, 6, and 7 to transactivate target genes including IGF2 (P3 promoter), GPX4, BCL2, MSI2, GDH1, and PLIN1; it is imported into the nucleus via karyopherin alpha2/NLS1; its transcriptional activity is repressed by SUMOylation at Lys-244/Lys-263 and activated by p300-mediated acetylation/reversed by HDAC7; in cancer and normal development it is frequently overexpressed via promoter-swapping gene fusions (CTNNB1-, CHCHD7-, TCEA1-, FGFR1-, LIFR-, HAS2-, COL1A2-PLAG1 and others) or by upstream HMGA2 transcriptional activation; functionally, PLAG1 drives cell proliferation and survival through IGF2-mTORC1 and PI3K-AKT signaling, promotes HSC dormancy and self-renewal by dampening protein synthesis via 4EBP1 and miR-127, supports spermatogenesis, and cooperates with CBFbeta-SMMHC to induce AML."},"narrative":{"mechanistic_narrative":"PLAG1 is a developmentally regulated, DNA-binding transcription factor that controls cell proliferation, survival, and organismal growth by activating target gene programs centered on insulin-like growth factor signaling [PMID:10646861, PMID:15606491, PMID:28796236]. It binds a bipartite consensus sequence (GRGGC core plus a downstream G-cluster separated by ~6–8 nucleotides) through zinc fingers 3, 6, and 7, and uses this activity to transactivate the IGF2/IGF-II P3 promoter and other targets enriched for the same motif [PMID:10646861, PMID:14712223]. Nuclear function depends on karyopherin alpha2-mediated import via the NLS1 (KRKR) sequence, and transcriptional output is set by competing post-translational modifications—SUMOylation at Lys-244/Lys-263/Lys-353 represses activity (and mislocalizes the protein to the nucleolus when lost), while p300-mediated acetylation activates it and HDAC7 reverses this [PMID:11882654, PMID:15208321, PMID:16207715]. A recurrent theme across normal and malignant tissues is PLAG1 dysregulation: in pleomorphic adenoma, lipoblastoma, and related tumors it is ectopically overexpressed through promoter-swapping fusions that place its coding sequence under constitutively active partner promoters (CTNNB1, TCEA1, CHCHD7, FGFR1, HAS2, COL1A2), and it is also activated downstream of HMGA2 or derepressed by loss of inhibitory microRNAs [PMID:10029085, PMID:10987300, PMID:16736500, PMID:18059337, PMID:24516594, PMID:19692702]. Functionally, PLAG1 drives growth through IGF2-dependent activation of AKT/MAPK and mTORC1 signaling, reinforces survival by transcribing BCL2 and the ferroptosis suppressor GPX4, and mediates metabolic adaptation via GDH1; genetic models show it is required for postnatal growth, spermatogenesis, neocortical progenitor balance, and cooperates with CBFbeta-SMMHC to induce acute myeloid leukemia [PMID:30026293, PMID:27013583, PMID:38745179, PMID:29249655, PMID:15606491, PMID:28706261, PMID:30361413, PMID:15585652]. In human hematopoietic stem cells PLAG1 promotes self-renewal by restraining protein synthesis through 4EBP1 and miR-127 and co-activates MSI2 with USF2 [PMID:35639948, PMID:29641991]. Loss-of-function PLAG1 mutations cause Silver-Russell syndrome with fetal growth restriction [PMID:28796236].","teleology":[{"year":2000,"claim":"Established PLAG1's core molecular identity by defining its sequence-specific DNA-binding mode and its first direct target, answering how an oncogenic transcription factor engages chromatin.","evidence":"In vitro DNA-binding and zinc-finger mutagenesis with transactivation reporters and IGF-II P3 promoter binding","pmids":["10646861"],"confidence":"High","gaps":["Genome-wide binding repertoire not yet defined","Cofactor requirements for transactivation unknown"]},{"year":2000,"claim":"Showed that PLAG1 oncogenicity arises chiefly from deregulated expression rather than coding mutation, by identifying promoter-swapping fusions that drive ectopic expression across distinct tumor types.","evidence":"5'-RACE, RT-PCR, sequencing of fusion transcripts in pleomorphic adenoma and lipoblastoma (CTNNB1, TCEA1, HAS2, COL1A2)","pmids":["10029085","10987300"],"confidence":"High","gaps":["Whether overexpression alone is sufficient for transformation not addressed","Downstream effector program not mapped"]},{"year":2002,"claim":"Defined how PLAG1 reaches the nucleus, identifying the NLS1 element and its import receptor required for function.","evidence":"Yeast two-hybrid, GST pull-down, NLS mutagenesis, and nuclear import reporter assays","pmids":["11882654"],"confidence":"High","gaps":["Regulation of import in different cell states unknown","Contribution of zinc-finger-mediated residual import not quantified"]},{"year":2005,"claim":"Resolved how PLAG1 transcriptional output is tuned, showing opposing control by repressive SUMOylation and activating p300 acetylation/HDAC7 deacetylation, linking modification state to subcellular localization and transforming capacity.","evidence":"In vivo SUMOylation and acetylation assays, lysine mutagenesis, localization, and transformation assays","pmids":["15208321","16207715"],"confidence":"High","gaps":["Signals controlling the SUMO/acetyl switch unknown","SUMO ligases acting on PLAG1 not identified"]},{"year":2004,"claim":"Defined the PLAG1 target gene program genome-wide and confirmed motif-driven regulation, anchoring IGF-II as a principal output.","evidence":"Oligonucleotide microarray on conditional PLAG1 cells with in silico promoter motif analysis and tumor-profile concordance","pmids":["14712223"],"confidence":"Medium","gaps":["Direct vs indirect targets not separated by binding data","Restricted to one cell context"]},{"year":2005,"claim":"Provided direct in vivo proof that PLAG1 overexpression is tumorigenic and activates imprinted growth loci, moving beyond correlative fusion data.","evidence":"Cre/loxP conditional PLAG1 transgenic mice with histopathology and Igf2/H19, Dlk1/Gtl2 expression analysis","pmids":["15930271"],"confidence":"High","gaps":["Mechanism of imprinted cluster activation unresolved","Cell-of-origin contributions not dissected"]},{"year":2008,"claim":"Tested the causal weight of IGF2 in PLAG1 tumorigenesis, revealing IGF2 is important but not solely responsible and implicating parallel Wnt signaling.","evidence":"Genetic epistasis (Igf2 inactivation on PLAG1-transgenic background) with tumor latency and target gene profiling","pmids":["18425330"],"confidence":"High","gaps":["Relative contribution of Wnt vs residual IGF signaling unquantified","Direct PLAG1 regulation of human Wnt targets unproven"]},{"year":2004,"claim":"Defined PLAG1's physiological roles and IGF2-independent functions using a clean knockout, distinguishing developmental requirement from its canonical IGF2 axis.","evidence":"Targeted Plag1 disruption in mice with growth, organ-weight, and Igf2 expression analysis; AML cooperation model with CBFbeta-SMMHC","pmids":["15606491","15585652"],"confidence":"High","gaps":["Identity of Igf2-independent growth effectors unknown","Tissue-specific target programs not defined"]},{"year":2009,"claim":"Showed PLAG1 is controlled post-transcriptionally, with microRNA loss derepressing PLAG1 protein independent of mRNA level, expanding the routes to its overexpression in cancer.","evidence":"miRNA profiling, 3'UTR luciferase reporters with mutagenesis, Western blot, and miRNA promoter methylation analysis in CLL","pmids":["19692702"],"confidence":"High","gaps":["Whether PLAG1 derepression is driver or passenger in CLL not established","Downstream consequences in B cells not defined"]},{"year":2014,"claim":"Placed PLAG1 downstream of HMGA2, establishing an HMGA2-PLAG1-IGF2 axis that explains PLAG1 activation in tumors lacking chromosome 8 rearrangements.","evidence":"HMGA2 and FGF1 stimulation with qRT-PCR in MCF-7 and stem cells, plus leiomyoma correlation; later WES of Silver-Russell families with functional pathway validation","pmids":["24516594","28796236"],"confidence":"High","gaps":["Direct HMGA2 binding at the PLAG1 locus not shown","Mechanism of HMGA2-driven PLAG1 transcription unresolved"]},{"year":2017,"claim":"Broadened PLAG1 effector biology beyond growth, demonstrating metabolic (GDH1/AMPK anti-anoikis) and developmental (spermatogenesis) functions through distinct target genes.","evidence":"Knockdown/overexpression, co-IP, metabolic assays and PDX for GDH1; Plag1 knockout testis RNA-seq and sperm phenotyping","pmids":["29249655","28706261"],"confidence":"High","gaps":["Direct PLAG1 binding at GDH1 and spermatogenesis loci not all confirmed","Context-specificity of metabolic axis unknown"]},{"year":2018,"claim":"Established PLAG1 as a regulator of stem/progenitor identity, mapping genome-wide occupancy and cooperative MSI2 activation with USF2 and a tumorigenic role in Wilms tumor via IGF2-mTORC1.","evidence":"ChIP-seq, reporter assays, cord blood and Wilms tumor in vitro/in vivo growth models","pmids":["29641991","30026293","30361413"],"confidence":"High","gaps":["Determinants of PLAG1-USF2 cooperativity not defined","How the same factor expands progenitors yet restrains self-renewal elsewhere unresolved"]},{"year":2024,"claim":"Connected PLAG1 to therapy resistance, showing transcriptional activation of survival/anti-ferroptosis genes (GPX4, BCL2) that modulate response to apoptotic and ferroptotic drugs.","evidence":"ChIP and luciferase reporter for GPX4/BCL2 promoters, knockdown with drug-sensitivity assays in HCC and AML; bovine myoblast/adipocyte PI3K-Akt and PLIN1 studies","pmids":["38745179","27013583","35325183","31981700"],"confidence":"Medium","gaps":["Generality of the resistance phenotype across tumor types unproven","Direct binding confirmed for some but not all survival targets"]},{"year":2022,"claim":"Defined a translational-control mechanism for PLAG1 in human HSCs, showing it dampens protein synthesis via 4EBP1 and miR-127 to enforce self-renewal, opposed by c-MYC.","evidence":"Genome-wide ChIP occupancy, RNA-seq, HSC functional assays, protein synthesis measurement, and c-MYC epistasis","pmids":["35639948"],"confidence":"High","gaps":["How PLAG1 toggles between pro-proliferative and translation-restraining programs unknown","Direct vs indirect regulation of 4EBP1/miR-127 not fully separated"]},{"year":null,"claim":"What determines whether PLAG1 acts as a growth-promoting oncogene versus a self-renewal-enforcing, translation-restraining regulator in a given cell remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking modification state, cofactor availability (USF2), and context-specific target selection","Structural basis of bipartite DNA recognition not solved","Mechanism by which the same factor restrains vs promotes proliferation not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,6,21,22,23,28,32]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,6,32]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,3]},{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[5]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,6,21,22]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[17,22,27]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[8,20,30]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[1,2,7,22,28]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[23,28]}],"complexes":[],"partners":["KPNA2","USF2","EP300","HDAC7"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q6DJT9","full_name":"Zinc finger protein PLAG1","aliases":["Pleiomorphic adenoma gene 1 protein"],"length_aa":500,"mass_kda":55.9,"function":"Transcription factor whose activation results in up-regulation of target genes, such as IGFII, leading to uncontrolled cell proliferation: when overexpressed in cultured cells, higher proliferation rate and transformation are observed. Other target genes such as CRLF1, CRABP2, CRIP2, PIGF are strongly induced in cells with PLAG1 induction. Proto-oncogene whose ectopic expression can trigger the development of pleomorphic adenomas of the salivary gland and lipoblastomas. Overexpression is associated with up-regulation of IGFII, is frequently observed in hepatoblastoma, common primary liver tumor in childhood. Cooperates with CBFB-MYH11, a fusion gene important for myeloid leukemia","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q6DJT9/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PLAG1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PLAG1","total_profiled":1310},"omim":[{"mim_id":"618908","title":"SILVER-RUSSELL SYNDROME 5; SRS5","url":"https://www.omim.org/entry/618908"},{"mim_id":"618907","title":"SILVER-RUSSELL SYNDROME 4; SRS4","url":"https://www.omim.org/entry/618907"},{"mim_id":"616489","title":"SILVER-RUSSELL SYNDROME 3; SRS3","url":"https://www.omim.org/entry/616489"},{"mim_id":"611238","title":"COILED-COIL-HELIX-COILED-COIL-HELIX DOMAIN-CONTAINING PROTEIN 7; CHCHD7","url":"https://www.omim.org/entry/611238"},{"mim_id":"604866","title":"PLAG1-LIKE ZINC FINGER 2; PLAGL2","url":"https://www.omim.org/entry/604866"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nuclear speckles","reliability":"Supported"},{"location":"Centrosome","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"retina","ntpm":7.2}],"url":"https://www.proteinatlas.org/search/PLAG1"},"hgnc":{"alias_symbol":["ZNF912"],"prev_symbol":[]},"alphafold":{"accession":"Q6DJT9","domains":[{"cath_id":"3.30.160","chopping":"119-174","consensus_level":"medium","plddt":69.4305,"start":119,"end":174}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q6DJT9","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q6DJT9-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q6DJT9-F1-predicted_aligned_error_v6.png","plddt_mean":55.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PLAG1","jax_strain_url":"https://www.jax.org/strain/search?query=PLAG1"},"sequence":{"accession":"Q6DJT9","fasta_url":"https://rest.uniprot.org/uniprotkb/Q6DJT9.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q6DJT9/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q6DJT9"}},"corpus_meta":[{"pmid":"29249655","id":"PMC_29249655","title":"The PLAG1-GDH1 Axis Promotes Anoikis Resistance and Tumor Metastasis through CamKK2-AMPK Signaling in LKB1-Deficient Lung Cancer.","date":"2017","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/29249655","citation_count":269,"is_preprint":false},{"pmid":"21516082","id":"PMC_21516082","title":"Variants modulating the expression of a chromosome domain encompassing PLAG1 influence bovine stature.","date":"2011","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21516082","citation_count":238,"is_preprint":false},{"pmid":"10987300","id":"PMC_10987300","title":"PLAG1 fusion oncogenes in lipoblastoma.","date":"2000","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/10987300","citation_count":187,"is_preprint":false},{"pmid":"10646861","id":"PMC_10646861","title":"PLAG1, the main translocation target in pleomorphic adenoma of the salivary glands, is a positive regulator of IGF-II.","date":"2000","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/10646861","citation_count":152,"is_preprint":false},{"pmid":"17332914","id":"PMC_17332914","title":"PLAG1, the prototype of the PLAG gene family: versatility in tumour development (review).","date":"2007","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/17332914","citation_count":130,"is_preprint":false},{"pmid":"15920557","id":"PMC_15920557","title":"PLAG1 gene alterations in salivary gland pleomorphic adenoma and carcinoma ex-pleomorphic adenoma: a combined study using chromosome banding, in situ hybridization and immunocytochemistry.","date":"2005","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/15920557","citation_count":128,"is_preprint":false},{"pmid":"10029085","id":"PMC_10029085","title":"Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities: identification of SII as a new fusion partner gene.","date":"1999","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/10029085","citation_count":123,"is_preprint":false},{"pmid":"19692702","id":"PMC_19692702","title":"miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia.","date":"2009","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19692702","citation_count":123,"is_preprint":false},{"pmid":"23630011","id":"PMC_23630011","title":"Frequent PLAG1 gene rearrangements in skin and soft tissue myoepithelioma with ductal differentiation.","date":"2013","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/23630011","citation_count":115,"is_preprint":false},{"pmid":"15585652","id":"PMC_15585652","title":"Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11.","date":"2004","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/15585652","citation_count":112,"is_preprint":false},{"pmid":"28796236","id":"PMC_28796236","title":"Genetic disruption of the oncogenic HMGA2-PLAG1-IGF2 pathway causes fetal growth restriction.","date":"2017","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28796236","citation_count":107,"is_preprint":false},{"pmid":"14712223","id":"PMC_14712223","title":"Microarray screening for target genes of the proto-oncogene PLAG1.","date":"2004","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/14712223","citation_count":105,"is_preprint":false},{"pmid":"11549588","id":"PMC_11549588","title":"PLAG1 alterations in lipoblastoma: involvement in varied mesenchymal cell types and evidence for alternative oncogenic mechanisms.","date":"2001","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/11549588","citation_count":101,"is_preprint":false},{"pmid":"21394649","id":"PMC_21394649","title":"Aberrant PLAG1 expression in pleomorphic adenomas of the salivary gland: a molecular genetic and immunohistochemical study.","date":"2011","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/21394649","citation_count":91,"is_preprint":false},{"pmid":"23909810","id":"PMC_23909810","title":"Evidence for pleiotropism and recent selection in the PLAG1 region in Australian Beef cattle.","date":"2013","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23909810","citation_count":87,"is_preprint":false},{"pmid":"14695992","id":"PMC_14695992","title":"Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma.","date":"2004","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/14695992","citation_count":82,"is_preprint":false},{"pmid":"16736500","id":"PMC_16736500","title":"CHCHD7-PLAG1 and TCEA1-PLAG1 gene fusions resulting from cryptic, intrachromosomal 8q rearrangements in pleomorphic salivary gland adenomas.","date":"2006","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/16736500","citation_count":81,"is_preprint":false},{"pmid":"26577933","id":"PMC_26577933","title":"Emerging role of PLAG1 as a regulator of growth and reproduction.","date":"2015","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/26577933","citation_count":80,"is_preprint":false},{"pmid":"28796899","id":"PMC_28796899","title":"PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities.","date":"2017","source":"Histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/28796899","citation_count":76,"is_preprint":false},{"pmid":"22485045","id":"PMC_22485045","title":"PLAG1 alteration in carcinoma ex pleomorphic adenoma: immunohistochemical and fluorescence in situ hybridization studies of 22 cases.","date":"2012","source":"Head and neck pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22485045","citation_count":75,"is_preprint":false},{"pmid":"30489320","id":"PMC_30489320","title":"Novel PLAG1 Gene Rearrangement Distinguishes a Subset of Uterine Myxoid Leiomyosarcoma From Other Uterine Myxoid Mesenchymal Tumors.","date":"2019","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/30489320","citation_count":73,"is_preprint":false},{"pmid":"15606491","id":"PMC_15606491","title":"Targeted disruption of the murine Plag1 proto-oncogene causes growth retardation and reduced fertility.","date":"2004","source":"Development, growth & differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/15606491","citation_count":73,"is_preprint":false},{"pmid":"15930271","id":"PMC_15930271","title":"Salivary gland tumors in transgenic mice with targeted PLAG1 proto-oncogene overexpression.","date":"2005","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/15930271","citation_count":71,"is_preprint":false},{"pmid":"27379604","id":"PMC_27379604","title":"Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.","date":"2016","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27379604","citation_count":70,"is_preprint":false},{"pmid":"22497486","id":"PMC_22497486","title":"Genetic variation in PLAG1 associates with early life body weight and peripubertal weight and growth in Bos taurus.","date":"2011","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22497486","citation_count":65,"is_preprint":false},{"pmid":"33027073","id":"PMC_33027073","title":"Molecular Profiling of Clear Cell Myoepithelial Carcinoma of Salivary Glands With EWSR1 Rearrangement Identifies Frequent PLAG1 Gene Fusions But No EWSR1 Fusion Transcripts.","date":"2021","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/33027073","citation_count":64,"is_preprint":false},{"pmid":"23554918","id":"PMC_23554918","title":"miR-141 contributes to fetal growth restriction by regulating PLAG1 expression.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23554918","citation_count":60,"is_preprint":false},{"pmid":"18059337","id":"PMC_18059337","title":"High-resolution array CGH analysis of salivary gland tumors reveals fusion and amplification of the FGFR1 and PLAG1 genes in ring chromosomes.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/18059337","citation_count":59,"is_preprint":false},{"pmid":"23738717","id":"PMC_23738717","title":"An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions.","date":"2013","source":"Histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/23738717","citation_count":58,"is_preprint":false},{"pmid":"11555676","id":"PMC_11555676","title":"Histologic localization of PLAG1 (pleomorphic adenoma gene 1) in pleomorphic adenoma of the salivary gland: cytogenetic evidence of common origin of phenotypically diverse cells.","date":"2001","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/11555676","citation_count":58,"is_preprint":false},{"pmid":"10811981","id":"PMC_10811981","title":"Evidence of involvement of the PLAG1 gene in lipoblastomas.","date":"2000","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/10811981","citation_count":56,"is_preprint":false},{"pmid":"23958548","id":"PMC_23958548","title":"Diagnostic utility of PLAG1 immunohistochemical determination in salivary gland tumors.","date":"2014","source":"Applied immunohistochemistry & molecular morphology : AIMM","url":"https://pubmed.ncbi.nlm.nih.gov/23958548","citation_count":53,"is_preprint":false},{"pmid":"24700772","id":"PMC_24700772","title":"Identification of COL3A1 and RAB2A as novel translocation partner genes of PLAG1 in lipoblastoma.","date":"2014","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24700772","citation_count":53,"is_preprint":false},{"pmid":"38745179","id":"PMC_38745179","title":"PLAG1 interacts with GPX4 to conquer vulnerability to sorafenib induced ferroptosis through a PVT1/miR-195-5p axis-dependent manner in hepatocellular carcinoma.","date":"2024","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/38745179","citation_count":47,"is_preprint":false},{"pmid":"33097826","id":"PMC_33097826","title":"Lipoblastomas presenting in older children and adults: analysis of 22 cases with identification of novel PLAG1 fusion partners.","date":"2020","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/33097826","citation_count":46,"is_preprint":false},{"pmid":"32345665","id":"PMC_32345665","title":"NDRG1-PLAG1 and TRPS1-PLAG1 Fusion Genes in Chondroid Syringoma.","date":"2020","source":"Cancer genomics & proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/32345665","citation_count":44,"is_preprint":false},{"pmid":"18425330","id":"PMC_18425330","title":"Upregulation of Igf and Wnt signalling associated genes in pleomorphic adenomas of the salivary glands in PLAG1 transgenic mice.","date":"2008","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/18425330","citation_count":44,"is_preprint":false},{"pmid":"28322319","id":"PMC_28322319","title":"Functional confirmation of PLAG1 as the candidate causative gene underlying major pleiotropic effects on body weight and milk characteristics.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28322319","citation_count":43,"is_preprint":false},{"pmid":"16108035","id":"PMC_16108035","title":"Wnt pathway is involved in pleomorphic adenomas induced by overexpression of PLAG1 in transgenic mice.","date":"2006","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/16108035","citation_count":42,"is_preprint":false},{"pmid":"29215042","id":"PMC_29215042","title":"A PLAG1 mutation contributed to stature recovery in modern cattle.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29215042","citation_count":41,"is_preprint":false},{"pmid":"25786906","id":"PMC_25786906","title":"SLIT2/ROBO1-miR-218-1-RET/PLAG1: a new disease pathway involved in Hirschsprung's disease.","date":"2015","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25786906","citation_count":40,"is_preprint":false},{"pmid":"22192798","id":"PMC_22192798","title":"PLAG1 expression in mesenchymal tumors: an immunohistochemical study with special emphasis on the pathogenetical distinction between soft tissue myoepithelioma and pleomorphic adenoma of the salivary gland.","date":"2011","source":"Pathology international","url":"https://pubmed.ncbi.nlm.nih.gov/22192798","citation_count":40,"is_preprint":false},{"pmid":"30307055","id":"PMC_30307055","title":"Clinicopathological effect of PLAG1 fusion genes in pleomorphic adenoma and carcinoma ex pleomorphic adenoma with special emphasis on histological features.","date":"2018","source":"Histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/30307055","citation_count":40,"is_preprint":false},{"pmid":"27473265","id":"PMC_27473265","title":"Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma.","date":"2016","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/27473265","citation_count":38,"is_preprint":false},{"pmid":"31981700","id":"PMC_31981700","title":"Function and characterization of the promoter region of perilipin 1 (PLIN1): Roles of E2F1, PLAG1, C/EBPβ, and SMAD3 in bovine adipocytes.","date":"2020","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/31981700","citation_count":37,"is_preprint":false},{"pmid":"30026293","id":"PMC_30026293","title":"Mutations in microRNA processing genes in Wilms tumors derepress the IGF2 regulator PLAG1.","date":"2018","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/30026293","citation_count":36,"is_preprint":false},{"pmid":"29735329","id":"PMC_29735329","title":"DNA methylation-mediated repression of miR-181a/135a/302c expression promotes the microsatellite-unstable colorectal cancer development and 5-FU resistance via targeting PLAG1.","date":"2018","source":"Journal of genetics and genomics = Yi chuan xue bao","url":"https://pubmed.ncbi.nlm.nih.gov/29735329","citation_count":36,"is_preprint":false},{"pmid":"23607392","id":"PMC_23607392","title":"Comparison of the effects explained by variations in the bovine PLAG1 and NCAPG genes on daily body weight gain, linear skeletal measurements and carcass traits in Japanese Black steers from a progeny testing program.","date":"2013","source":"Animal science journal = Nihon chikusan Gakkaiho","url":"https://pubmed.ncbi.nlm.nih.gov/23607392","citation_count":36,"is_preprint":false},{"pmid":"29437290","id":"PMC_29437290","title":"Recurrent rearrangements of the PLAG1 and HMGA2 genes in lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma.","date":"2018","source":"Acta ophthalmologica","url":"https://pubmed.ncbi.nlm.nih.gov/29437290","citation_count":35,"is_preprint":false},{"pmid":"16207715","id":"PMC_16207715","title":"Sumoylation and acetylation play opposite roles in the transactivation of PLAG1 and PLAGL2.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16207715","citation_count":32,"is_preprint":false},{"pmid":"36624091","id":"PMC_36624091","title":"Circular RNA circPOFUT1 enhances malignant phenotypes and autophagy-associated chemoresistance via sequestrating miR-488-3p to activate the PLAG1-ATG12 axis in gastric cancer.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/36624091","citation_count":30,"is_preprint":false},{"pmid":"15208321","id":"PMC_15208321","title":"Repression of the Transactivating Capacity of the Oncoprotein PLAG1 by SUMOylation.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15208321","citation_count":30,"is_preprint":false},{"pmid":"33300192","id":"PMC_33300192","title":"Pediatric fibromyxoid soft tissue tumor with PLAG1 fusion: A novel entity?","date":"2020","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/33300192","citation_count":30,"is_preprint":false},{"pmid":"23890983","id":"PMC_23890983","title":"A novel PLAG1-RAD51L1 gene fusion resulting from a t(8;14)(q12;q24) in a case of lipoblastoma.","date":"2013","source":"Cancer genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23890983","citation_count":30,"is_preprint":false},{"pmid":"24516594","id":"PMC_24516594","title":"Correlated expression of HMGA2 and PLAG1 in thyroid tumors, uterine leiomyomas and experimental models.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24516594","citation_count":29,"is_preprint":false},{"pmid":"34063412","id":"PMC_34063412","title":"Methylation and Expression of FTO and PLAG1 Genes in Childhood Obesity: Insight into Anthropometric Parameters and Glucose-Lipid Metabolism.","date":"2021","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/34063412","citation_count":28,"is_preprint":false},{"pmid":"26492619","id":"PMC_26492619","title":"Development of Monoclonal Antibody LpMab-10 Recognizing Non-glycosylated PLAG1/2 Domain Including Thr34 of Human Podoplanin.","date":"2015","source":"Monoclonal antibodies in immunodiagnosis and immunotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/26492619","citation_count":28,"is_preprint":false},{"pmid":"21927843","id":"PMC_21927843","title":"PLAG1 expression in cutaneous mixed tumors: an immunohistochemical and molecular genetic study.","date":"2011","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/21927843","citation_count":27,"is_preprint":false},{"pmid":"30839344","id":"PMC_30839344","title":"Differential Expression of PLAG1 in Apocrine and Eccrine Cutaneous Mixed Tumors: Evidence for Distinct Molecular Pathogenesis.","date":"2020","source":"The American Journal of dermatopathology","url":"https://pubmed.ncbi.nlm.nih.gov/30839344","citation_count":27,"is_preprint":false},{"pmid":"11882654","id":"PMC_11882654","title":"Identification of a karyopherin alpha 2 recognition site in PLAG1, which functions as a nuclear localization signal.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11882654","citation_count":27,"is_preprint":false},{"pmid":"30857637","id":"PMC_30857637","title":"Identification of a novel BOC-PLAG1 fusion gene in a case of lipoblastoma.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30857637","citation_count":26,"is_preprint":false},{"pmid":"29913240","id":"PMC_29913240","title":"Detection of 19-bp deletion within PLAG1 gene and its effect on growth traits in cattle.","date":"2018","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/29913240","citation_count":25,"is_preprint":false},{"pmid":"31094927","id":"PMC_31094927","title":"Metastasizing Pleomorphic Adenoma: Recurrent PLAG1/HMGA2 Rearrangements and Identification of a Novel HMGA2-TMTC2 Fusion.","date":"2019","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/31094927","citation_count":25,"is_preprint":false},{"pmid":"28706261","id":"PMC_28706261","title":"PLAG1 deficiency impairs spermatogenesis and sperm motility in mice.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28706261","citation_count":24,"is_preprint":false},{"pmid":"29641991","id":"PMC_29641991","title":"PLAG1 and USF2 Co-regulate Expression of Musashi-2 in Human Hematopoietic Stem and Progenitor Cells.","date":"2018","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29641991","citation_count":24,"is_preprint":false},{"pmid":"30675516","id":"PMC_30675516","title":"Assessment of HMGA2 and PLAG1 rearrangements in breast adenomyoepitheliomas.","date":"2019","source":"NPJ breast cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30675516","citation_count":24,"is_preprint":false},{"pmid":"30390196","id":"PMC_30390196","title":"Expression of PTEN, Androgen Receptor, HER2/neu, Cytokeratin 5/6, Estrogen Receptor-Beta, HMGA2, and PLAG1 in Salivary Duct Carcinoma.","date":"2018","source":"Head and neck pathology","url":"https://pubmed.ncbi.nlm.nih.gov/30390196","citation_count":24,"is_preprint":false},{"pmid":"27013583","id":"PMC_27013583","title":"MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27013583","citation_count":24,"is_preprint":false},{"pmid":"32683589","id":"PMC_32683589","title":"Hsa-circRNA-103809 Promotes Hepatocellular Carcinoma Development via MicroRNA-1270/PLAG1 Like Zinc Finger 2 Axis.","date":"2020","source":"Digestive diseases and sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32683589","citation_count":24,"is_preprint":false},{"pmid":"35639948","id":"PMC_35639948","title":"PLAG1 dampens protein synthesis to promote human hematopoietic stem cell self-renewal.","date":"2022","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/35639948","citation_count":23,"is_preprint":false},{"pmid":"23023303","id":"PMC_23023303","title":"Cell type and context-specific function of PLAG1 for IGF2 P3 promoter activity.","date":"2012","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/23023303","citation_count":23,"is_preprint":false},{"pmid":"28012286","id":"PMC_28012286","title":"Expression and Clinical Significance of miR-26a and Pleomorphic Adenoma Gene 1 (PLAG1) in Invasive Pituitary Adenoma.","date":"2016","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/28012286","citation_count":23,"is_preprint":false},{"pmid":"34184333","id":"PMC_34184333","title":"PLAG1-rearrangment in a uterine leiomyosarcoma with myxoid stroma and heterologous differentiation.","date":"2021","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34184333","citation_count":23,"is_preprint":false},{"pmid":"18425334","id":"PMC_18425334","title":"MMTV-cre-mediated fur inactivation concomitant with PLAG1 proto-oncogene activation delays salivary gland tumorigenesis in mice.","date":"2008","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/18425334","citation_count":23,"is_preprint":false},{"pmid":"38266920","id":"PMC_38266920","title":"SOX10-Internal Tandem Duplications and PLAG1 or HMGA2 Fusions Segregate Eccrine-Type and Apocrine-Type Cutaneous Mixed Tumors.","date":"2024","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/38266920","citation_count":22,"is_preprint":false},{"pmid":"30424592","id":"PMC_30424592","title":"PLAG1, SOX10, and Myb Expression in Benign and Malignant Salivary Gland Neoplasms.","date":"2018","source":"Journal of pathology and translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30424592","citation_count":22,"is_preprint":false},{"pmid":"30361413","id":"PMC_30361413","title":"Plag1 and Plagl2 have overlapping and distinct functions in telencephalic development.","date":"2018","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/30361413","citation_count":21,"is_preprint":false},{"pmid":"26701195","id":"PMC_26701195","title":"Undifferentiated myxoid lipoblastoma with PLAG1-HAS2 fusion in an infant; morphologically mimicking primitive myxoid mesenchymal tumor of infancy (PMMTI)--diagnostic importance of cytogenetic and molecular testing and literature review.","date":"2015","source":"Cancer genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26701195","citation_count":21,"is_preprint":false},{"pmid":"32654217","id":"PMC_32654217","title":"Activation of PLAG1 and HMGA2 by gene fusions involving the transcriptional regulator gene NFIB.","date":"2020","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32654217","citation_count":20,"is_preprint":false},{"pmid":"30580072","id":"PMC_30580072","title":"A novel SNP of PLAG1 gene and its association with growth traits in Chinese cattle.","date":"2018","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/30580072","citation_count":19,"is_preprint":false},{"pmid":"17693184","id":"PMC_17693184","title":"Heterogeneity of PLAG1 gene rearrangements in pleomorphic adenoma.","date":"2007","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/17693184","citation_count":19,"is_preprint":false},{"pmid":"33230916","id":"PMC_33230916","title":"Recent advances in smooth muscle tumors with PGR and PLAG1 gene fusions and myofibroblastic uterine neoplasms.","date":"2020","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/33230916","citation_count":18,"is_preprint":false},{"pmid":"35822448","id":"PMC_35822448","title":"3'RNA and whole-genome sequencing of archival uterine leiomyomas reveal a tumor subtype with chromosomal rearrangements affecting either HMGA2, HMGA1, or PLAG1.","date":"2022","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/35822448","citation_count":18,"is_preprint":false},{"pmid":"33893698","id":"PMC_33893698","title":"Novel morphologic findings in PLAG1-rearranged soft tissue tumors.","date":"2021","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/33893698","citation_count":18,"is_preprint":false},{"pmid":"18097540","id":"PMC_18097540","title":"aP2-Cre-mediated expression activation of an oncogenic PLAG1 transgene results in cavernous angiomatosis in mice.","date":"2008","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/18097540","citation_count":18,"is_preprint":false},{"pmid":"34292619","id":"PMC_34292619","title":"Some pleomorphic adenomas of the breast share PLAG1 rearrangements with the analogous tumour of the salivary glands.","date":"2021","source":"Histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/34292619","citation_count":18,"is_preprint":false},{"pmid":"27463119","id":"PMC_27463119","title":"PLAG1: An Immunohistochemical Marker with Limited Utility in Separating Pleomorphic Adenoma from Other Basaloid Salivary Gland Tumors.","date":"2016","source":"Acta cytologica","url":"https://pubmed.ncbi.nlm.nih.gov/27463119","citation_count":18,"is_preprint":false},{"pmid":"9892112","id":"PMC_9892112","title":"Fluorescence in situ hybridization mapping of breakpoints in pleomorphic adenomas with 8q12-13 abnormalities identifies a subgroup of tumors without PLAG1 involvement.","date":"1999","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/9892112","citation_count":16,"is_preprint":false},{"pmid":"31922228","id":"PMC_31922228","title":"PLAG1 silencing promotes cell chemosensitivity in ovarian cancer via the IGF2 signaling pathway.","date":"2020","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31922228","citation_count":15,"is_preprint":false},{"pmid":"31757836","id":"PMC_31757836","title":"Bayesian Modeling Identifies PLAG1 as a Key Regulator of Proliferation and Survival in Rhabdomyosarcoma Cells.","date":"2019","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/31757836","citation_count":15,"is_preprint":false},{"pmid":"22223189","id":"PMC_22223189","title":"Rearrangement of HMGA2 in a case of infantile lipoblastoma without Plag1 alteration.","date":"2012","source":"Pediatric blood & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/22223189","citation_count":15,"is_preprint":false},{"pmid":"38942115","id":"PMC_38942115","title":"PLAG1-Rearranged Uterine Sarcomas: A Study of 11 Cases Showing a Wide Phenotypical Spectrum Not Limited to Myxoid Leiomyosarcoma-Like Morphology.","date":"2024","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/38942115","citation_count":14,"is_preprint":false},{"pmid":"33291420","id":"PMC_33291420","title":"Novel Variant in PLAG1 in a Familial Case with Silver-Russell Syndrome Suspicion.","date":"2020","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/33291420","citation_count":14,"is_preprint":false},{"pmid":"18649356","id":"PMC_18649356","title":"Adenomyoepitheliomatous lesions of the mammary glands in transgenic mice with targeted PLAG1 overexpression.","date":"2008","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/18649356","citation_count":14,"is_preprint":false},{"pmid":"31643102","id":"PMC_31643102","title":"A SNP in PLAG1 is associated with body height trait in Chinese cattle.","date":"2019","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31643102","citation_count":14,"is_preprint":false},{"pmid":"18160779","id":"PMC_18160779","title":"PLAG1 activation in lipoblastoma coinciding with low-level amplification of a derivative chromosome 8 with a deletion del(8)(q13q21.2).","date":"2007","source":"Cytogenetic and genome research","url":"https://pubmed.ncbi.nlm.nih.gov/18160779","citation_count":14,"is_preprint":false},{"pmid":"20687796","id":"PMC_20687796","title":"Critical role of microRNAs in chronic lymphocytic leukemia: overexpression of the oncogene PLAG1 by deregulated miRNAs.","date":"2010","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/20687796","citation_count":14,"is_preprint":false},{"pmid":"33825658","id":"PMC_33825658","title":"Indel mutations of sheep PLAG1 gene and their associations with growth traits.","date":"2021","source":"Animal biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/33825658","citation_count":13,"is_preprint":false},{"pmid":"31253059","id":"PMC_31253059","title":"The PLAG1 mRNA expression analysis among genetic variants and relevance to growth traits in Chinese cattle.","date":"2019","source":"Animal biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/31253059","citation_count":12,"is_preprint":false},{"pmid":"35325183","id":"PMC_35325183","title":"Pleomorphic adenoma gene 1 (PLAG1) promotes proliferation and inhibits apoptosis of bovine primary myoblasts through the PI3K-Akt signaling pathway.","date":"2022","source":"Journal of animal science","url":"https://pubmed.ncbi.nlm.nih.gov/35325183","citation_count":12,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54515,"output_tokens":8233,"usd":0.14352,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17752,"output_tokens":4802,"usd":0.104405,"stage2_stop_reason":"end_turn"},"total_usd":0.247925,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"PLAG1 is a nuclear protein that binds DNA in a sequence-specific manner via a bipartite consensus sequence (GRGGC core + RGGK G-cluster separated by 7 random nucleotides); DNA binding is mediated mainly by zinc fingers 3, 6, and 7. PLAG1 activates transcription from this consensus site and directly binds the IGF-II P3 promoter, stimulating IGF-II expression.\",\n      \"method\": \"DNA binding assays, transient transactivation assays, zinc finger mutagenesis, promoter binding studies\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro DNA-binding assays with mutagenesis of individual zinc fingers, transactivation reporter assays, and promoter binding experiments, all in a single rigorous study\",\n      \"pmids\": [\"10646861\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"PLAG1 is activated in pleomorphic adenomas by promoter swapping with constitutively expressed partner genes (CTNNB1/beta-catenin, TCEA1/SII), where fusions in the 5' noncoding region exchange regulatory elements and drive ectopic PLAG1 expression. This mechanism operates even in tumors with grossly normal karyotypes via cryptic rearrangements.\",\n      \"method\": \"Northern blot, RNase protection, 5'-RACE, RT-PCR, nucleotide sequencing\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — replicated across multiple labs and tumor types; multiple orthogonal molecular methods (RACE, RT-PCR, sequencing) identifying fusion transcripts\",\n      \"pmids\": [\"10029085\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"PLAG1 is activated in lipoblastoma via promoter-swapping events fusing the HAS2 or COL1A2 gene promoter to the PLAG1 coding sequence, driving ectopic PLAG1 overexpression in a non-epithelial tumor context.\",\n      \"method\": \"Cytogenetics, RT-PCR, promoter fusion analysis\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple independent lipoblastoma cases, replicated by several subsequent studies confirming the same promoter-swapping mechanism\",\n      \"pmids\": [\"10987300\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"PLAG1 is imported into the nucleus via interaction with karyopherin alpha2 (importin-alpha2). The NLS1 sequence (KRKR) in PLAG1 is essential for physical interaction with karyopherin alpha2 and for nuclear import; the zinc finger domain also contributes to residual nuclear import independently of NLS1.\",\n      \"method\": \"Yeast two-hybrid, GST pull-down assay, NLS mutagenesis, nuclear import assay with beta-galactosidase reporter\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution with GST pull-down, mutagenesis of NLS, and functional nuclear import assays in a single study\",\n      \"pmids\": [\"11882654\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PLAG1 transactivating capacity is repressed by SUMOylation at Lys-244 and Lys-263. Mutation of both SUMO consensus sites inhibits SUMOylation and significantly increases PLAG1 transactivation; SUMO-1-modified forms of PLAG1 (single and double) were detected endogenously.\",\n      \"method\": \"In vivo SUMOylation assay, site-directed mutagenesis of SUMO consensus sites, transactivation reporter assays, anti-PLAG1 immunoblot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis of specific lysines combined with in vivo SUMOylation assay and functional transactivation readout in one rigorous study\",\n      \"pmids\": [\"15208321\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"PLAG1 is regulated by both SUMOylation (repressive) and acetylation (activating). PLAG1 is acetylated and activated by p300 and deacetylated and repressed by HDAC7. A conserved transcriptional repression domain depends on three sumoylation motifs; sumoylation at Lys-244, Lys-263, and Lys-353 inhibits PLAG1-induced IGF-II expression. Sumoylation-deficient PLAG1 localizes to the nucleolus rather than the nucleus. Mutation of the three sumoylation-site lysines significantly impairs PLAG1 transformation ability.\",\n      \"method\": \"In vivo sumoylation assay, acetylation assay with p300/HDAC7 overexpression, reporter assays, subcellular localization, transformation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal methods (sumoylation, acetylation, localization, transformation) in one study, with site-specific mutagenesis\",\n      \"pmids\": [\"16207715\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PLAG1 microarray analysis identified 47 induced and 12 repressed target genes upon conditional induction in fetal kidney 293 cells. Major upregulated targets include IGF-II and cytokine-like factor 1; the consensus PLAG1 binding motif GRGGC(N)6-8GGG was enriched in promoters of upregulated genes. Concordance with pleomorphic adenoma expression profiles identified 12 consistent PLAG1 target genes.\",\n      \"method\": \"Oligonucleotide microarray of ~12,000 genes in conditional PLAG1 expression cell lines, in silico promoter analysis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-scale expression profiling with conditional induction, validated by comparison with tumor expression data, single lab\",\n      \"pmids\": [\"14712223\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Plag1 and Plagl2 independently cooperate with CBFbeta-SMMHC in vivo to induce acute myeloid leukemia with short latency in mice. Plag1 promotes G1-to-S phase transition and expands hematopoietic progenitors in vitro.\",\n      \"method\": \"In vivo mouse leukemia model, in vitro proliferation and cell cycle assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo mouse leukemia model with defined genetic cooperation and in vitro cell cycle phenotype, replicated with multiple mouse cohorts\",\n      \"pmids\": [\"15585652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Targeted disruption of murine Plag1 causes postnatal growth retardation and reduced fertility in both male and female mice. Plag1-/- mice have proportionally smaller organs except for disproportionally small seminal vesicles and ventral prostate. Igf2 expression is not affected in Plag1-/- embryos, suggesting Plag1 regulates postnatal growth through Igf2-independent mechanisms as well.\",\n      \"method\": \"Targeted gene disruption, growth measurement, organ weight analysis, Northern blot for Igf2\",\n      \"journal\": \"Development, growth & differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic KO with defined phenotypic readouts, confirmed negative Igf2 result adds mechanistic specificity\",\n      \"pmids\": [\"15606491\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Conditional PLAG1 overexpression in salivary and mammary glands of transgenic mice induces pleomorphic adenomas with upregulation of the Igf2/H19 and Dlk1/Gtl2 imprinted gene clusters, establishing a direct in vivo tumorigenic role for PLAG1.\",\n      \"method\": \"Cre/loxP conditional transgenic mouse model, histopathology, gene expression analysis\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two independent founder strains, 100% tumor penetrance in one line, in vivo target gene expression validated\",\n      \"pmids\": [\"15930271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PLAG1 transactivates transcription from the embryonic IGF2 P3 promoter in hepatoblastoma cell lines, as demonstrated by luciferase reporter assays, linking PLAG1 overexpression to IGF2 upregulation in hepatoblastoma.\",\n      \"method\": \"Luciferase reporter assay in hepatoblastoma cell lines, real-time RT-PCR\",\n      \"journal\": \"Genes, chromosomes & cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional transactivation assay in cell lines, supported by expression correlation, single lab\",\n      \"pmids\": [\"14695992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CHCHD7-PLAG1 is a recurrent gene fusion in pleomorphic adenomas generated by a cryptic intrachromosomal 8q rearrangement, where CHCHD7 (located head-to-head ~500 bp from PLAG1) provides its promoter to drive PLAG1 expression by promoter swapping. PLAG1 protein is overexpressed in epithelial, myoepithelial, and mesenchymal-like tumor cells in these tumors.\",\n      \"method\": \"Cytogenetics, molecular analysis, Northern blot, Western blot, immunohistochemistry, FISH on nuclear chromatin fibers\",\n      \"journal\": \"Genes, chromosomes & cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (cytogenetics, molecular analysis, protein expression) confirming fusion and promoter-swapping mechanism\",\n      \"pmids\": [\"16736500\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PLAG1 activates transcription of mouse (but not human) beta-catenin; four PLAG1 consensus binding sites are present in the mouse beta-catenin promoter but not in human. In PLAG1 transgenic mouse tumors, beta-catenin and downstream Wnt target c-myc are upregulated at the transcriptional level.\",\n      \"method\": \"Cotransfection reporter assay in 3T3 cells, promoter sequence analysis, immunohistochemistry\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assay with sequence analysis, supported by in vivo IHC in transgenic model, single lab\",\n      \"pmids\": [\"16108035\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Inactivation of Igf2 in PLAG1-transgenic mice (P1-MCre) significantly delays salivary gland tumor development but does not fully abrogate it; Wnt signaling genes (Wnt6, Cyclin D1, beta-catenin), H19, Dlk1, Gtl2, Igfbp2, and Igfbp3 are upregulated in the Igf2-inactivated PLAG1 tumors, indicating both IGF and Wnt signaling contribute to PLAG1-induced tumorigenesis.\",\n      \"method\": \"Genetic epistasis in conditional transgenic mice (Igf2 inactivation on PLAG1-OE background), tumor latency measurement, gene expression analysis\",\n      \"journal\": \"International journal of oncology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic epistasis experiment in vivo with defined phenotypic readout (tumor latency) and target gene expression validation\",\n      \"pmids\": [\"18425330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"FGFR1-PLAG1 fusion genes are generated by ring chromosome formation from chromosome 8; the 5' part of FGFR1 (8p12) is linked to the PLAG1 coding sequence (8q12.1), providing an active promoter to drive PLAG1 expression.\",\n      \"method\": \"SKY, FISH, high-resolution oligonucleotide array-CGH, molecular analysis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple genomic methods confirming fusion gene structure, single lab\",\n      \"pmids\": [\"18059337\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PLAG1 protein expression is elevated in CLL cells compared to normal B cells due to translational derepression, caused by epigenetic silencing (methylation) of miR-181a, miR-181b, miR-107, and miR-424. Luciferase reporter assays with site-directed mutagenesis of the PLAG1 3'UTR confirmed direct regulation of PLAG1 by these miRNAs. PLAG1 mRNA levels were not affected, demonstrating post-transcriptional regulation.\",\n      \"method\": \"miRNA expression profiling, luciferase reporter assays with site-directed mutagenesis of 3'UTR binding sites, Western blot, methylation analysis of miRNA promoters\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — luciferase reporter with mutagenesis of specific binding sites plus Western blot protein quantification, demonstrating post-transcriptional mechanism\",\n      \"pmids\": [\"19692702\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PLAG1 binding to the IGF2 P3 promoter is cell type-specific; ChIP shows PLAG1 binding in Hep3B but not JEG-3 cells at the endogenous locus. The H19 chromatin insulator modulates PLAG1 responsiveness in a cell type-dependent manner. PLAG1 induction partially overrides insulator function in reporter systems but does not consistently activate the endogenous IGF2 gene in JEG-3 cells.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), GFP reporter/insulator assay, FACS analysis of stable inducible PLAG1 cell clones\",\n      \"journal\": \"International journal of oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and functional reporter assays, but conclusions limited to two cell lines and endogenous locus was partially refractory\",\n      \"pmids\": [\"23023303\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PLAG1 upregulates GDH1 (glutamate dehydrogenase 1) expression upon cell detachment, providing anti-anoikis signals in LKB1-deficient lung cancer. The GDH1 product alpha-KG activates CamKK2 by enhancing its substrate AMPK binding, promoting energy production conferring anoikis resistance. This establishes a PLAG1-GDH1-alpha-KG-CamKK2-AMPK axis.\",\n      \"method\": \"Genetic knockdown/overexpression, biochemical assays, patient-derived xenograft model, co-immunoprecipitation\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mechanistic pathway placement via multiple orthogonal experiments including KD, co-IP, metabolic assays, and in vivo PDX validation\",\n      \"pmids\": [\"29249655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Functional experiments demonstrate that HMGA2 regulates IGF2 expression through PLAG1, establishing a HMGA2-PLAG1-IGF2 regulatory pathway. Loss-of-function mutations in PLAG1 in humans cause Silver-Russell syndrome with fetal growth restriction. HMGA2 also regulates IGF2 in a PLAG1-independent manner.\",\n      \"method\": \"Whole-exome sequencing, targeted sequencing, functional experiments linking genes in the pathway\",\n      \"journal\": \"Genetics in medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — human loss-of-function mutations identified and functionally validated in a pathway context, replicated across multiple families\",\n      \"pmids\": [\"28796236\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"HMGA2 overexpression in MCF-7 cells induces increased PLAG1 mRNA expression within 24–48 hours, and stimulation of HMGA2 by FGF1 in adipose-derived stem cells simultaneously increases PLAG1 mRNA. In leiomyomas with HMGA2 overexpression but no chromosome 8 abnormalities, PLAG1 is consistently activated, suggesting HMGA2 is an upstream transcriptional activator of PLAG1.\",\n      \"method\": \"Transient transfection of HMGA2 in MCF-7 cells, FGF1 stimulation assay, quantitative RT-PCR\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — transient transfection with mRNA quantification, supported by human tumor correlations, single lab\",\n      \"pmids\": [\"24516594\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PLAG1 deficiency in male mice results in significantly reduced daily sperm production, reduced sperm motility, and sloughing of the germinal epithelium. PLAG1 is expressed in germ cells and Sertoli cells. Genes involved in spermatogenesis and Hsd17b3 (androgen biosynthesis) are downregulated in Plag1 knockout testes.\",\n      \"method\": \"Plag1 knockout mouse analysis, X-gal staining for localization, RNA-seq, testicular histology, sperm motility assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with multiple quantitative phenotypic readouts (sperm production, motility) and genome-wide expression profiling to identify downstream target genes\",\n      \"pmids\": [\"28706261\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PLAG1 and USF2 co-occupy the MSI2 promoter in human hematopoietic stem and progenitor cells (HSPCs) and cooperate to transactivate endogenous MSI2. Coincident overexpression of PLAG1 and USF2 in cord blood progenitors enhances MSI2 transcription and expands CD34+ cells in vitro. ChIP-seq confirms co-binding of PLAG1 and USF2 at the MSI2 promoter and other HSPC regulatory loci.\",\n      \"method\": \"ChIP-seq, luciferase reporter assays, PLAG1/USF2 overexpression in cord blood cells, FACS for CD34+ expansion\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq with functional validation (reporter assay and cellular phenotype), multiple orthogonal methods in one study\",\n      \"pmids\": [\"29641991\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PLAG1 is a microRNA target gene derepressed by mutations in microRNA biogenesis machinery in Wilms tumors. PLAG1 overexpression accelerates Wilms tumor cell growth in vitro and induces neoplastic growth in the developing mouse kidney in vivo by transactivating IGF2 and driving mTORC1 signaling.\",\n      \"method\": \"In vitro cell growth assays, in vivo mouse kidney injection model, luciferase reporter for IGF2 transactivation, pathway analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vitro and in vivo functional models with mechanistic pathway placement (PLAG1→IGF2→mTORC1), single lab with multiple orthogonal approaches\",\n      \"pmids\": [\"30026293\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PLAG1 as a transcription factor reinforces BCL2 promoter activity, upregulating BCL2 mRNA; knockdown of PLAG1 reduces BCL2 expression and sensitizes AML cells to TRAIL-induced apoptosis and proliferation inhibition. Restoration of BCL2 eliminates the sensitizing effects of PLAG1 knockdown.\",\n      \"method\": \"BCL2 promoter luciferase reporter assay, PLAG1 siRNA knockdown, apoptosis and proliferation assays, BCL2 restoration rescue experiment\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assay for BCL2 promoter plus KD phenotype with rescue, single lab\",\n      \"pmids\": [\"27013583\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PLAG1 is essential for long-term human HSC function and promotes HSC self-renewal by dampening protein synthesis. Genome-wide ChIP occupancy and gene expression analysis show PLAG1 restrains translation via upregulating 4EBP1 and translation-targeting miR-127, independently of stress response signaling. The advantages conferred by PLAG1 are attenuated by c-MYC overexpression.\",\n      \"method\": \"Genome-wide chromatin occupancy (ChIP-seq), RNA-seq, functional HSC assays, in vitro protein synthesis measurement, genetic epistasis with c-MYC\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide occupancy data combined with functional HSC assays and mechanistic epistasis (PLAG1 vs. c-MYC), multiple orthogonal methods in one study\",\n      \"pmids\": [\"35639948\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PLAG1 promotes proliferation and inhibits apoptosis in bovine primary myoblasts by upregulating phosphorylated PI3K/Akt, Cyclin D1, and CDK2 (via ChIP-seq evidence) and upregulating Bcl-2/Bcl-xL while inhibiting p21/p27. PLAG1 is a direct target of miR-1, which negatively regulates PLAG1 expression.\",\n      \"method\": \"CCK-8 assay, EdU proliferation assay, ChIP-seq, flow cytometry, Western blot, dual-luciferase assay for miR-1 targeting\",\n      \"journal\": \"Journal of animal science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq combined with functional assays and validated miR-1 targeting by luciferase assay, single lab in bovine model\",\n      \"pmids\": [\"35325183\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PLAG1 silencing in ovarian cancer cells decreases expression of IGF2, IGF1 receptor, and IRS1, and inhibits cell proliferation, migration, invasion, and cisplatin resistance in an IGF2-dependent manner.\",\n      \"method\": \"siRNA knockdown, pcDNA overexpression, cell proliferation/migration/invasion assays, Western blot\",\n      \"journal\": \"International journal of molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — siRNA KD with functional phenotype and IGF2-dependence rescue, single lab\",\n      \"pmids\": [\"31922228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PLAG1 promotes proliferation and survival of rhabdomyosarcoma cells by inducing IGF2 expression and activating AKT and MAPK pathways. IGF2 partially rescues cell death triggered by PLAG1 knockdown. PLAG1 expression level correlates with sensitivity to IGF receptor inhibitor BMS754807.\",\n      \"method\": \"PLAG1 knockdown and ectopic overexpression, xenograft model, pathway activation assays (AKT/MAPK), IGF2 rescue experiment\",\n      \"journal\": \"Molecular cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KD/OE with in vivo xenograft and pathway analysis, including rescue experiment confirming IGF2 dependence, single lab\",\n      \"pmids\": [\"31757836\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PLAG1 confers resistance to sorafenib-induced ferroptosis in HCC by transcriptionally driving expression of GPX4 (glutathione peroxidase 4), thereby reducing lipid peroxidation. Sorafenib decreases PLAG1 at the transcriptional level through its upstream lncRNA PVT1. ChIP assay confirmed PLAG1 binding to the GPX4 promoter; PLAG1 and GPX4 protein levels are positively correlated in HCC patients.\",\n      \"method\": \"ChIP assay, luciferase reporter assay, ubiquitination assay, RNA immunoprecipitation (RIP) assay, CRISPR screening, tissue microarrays\",\n      \"journal\": \"Journal of experimental & clinical cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assay establishing PLAG1→GPX4 transcriptional axis, supported by patient tissue data, single lab\",\n      \"pmids\": [\"38745179\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"In Wilms tumors, PLAG1 promoter occupancy by ChIP-seq analysis and MSI2 co-regulation experiments establish that PLAG1 directly activates MSI2 transcription in HSPCs alongside USF2.\",\n      \"method\": \"ChIP-seq\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq confirmation of co-binding, single lab\",\n      \"pmids\": [\"29641991\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Plag1 mutant neocortical progenitors proliferate less and produce more neurons at E12.5, while Plag1 gain-of-function reduces neurogenesis and increases BrdU uptake (enhanced proliferation). Plag1 and Plagl2 double-mutants are embryonic lethal, indicating at least one copy of either gene is required for embryonic survival.\",\n      \"method\": \"Single and double mutant mouse analysis, BrdU labeling, neurogenesis quantification in neocortex\",\n      \"journal\": \"Biology open\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO and overexpression in vivo with quantitative cellular phenotype, single lab\",\n      \"pmids\": [\"30361413\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Furin (proprotein convertase) facilitates PLAG1-induced salivary gland tumorigenesis; genetic ablation of fur with PLAG1 overexpression significantly delays tumor onset, and fur inactivation alone causes smaller but histologically normal salivary glands.\",\n      \"method\": \"MMTV-Cre genetic epistasis in mice (fur KO on PLAG1 transgenic background), histopathology, tumor latency measurement\",\n      \"journal\": \"International journal of oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in vivo showing furin cooperates with PLAG1, single lab\",\n      \"pmids\": [\"18425334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PLAG1 acts as a transcriptional activator of PLIN1 (perilipin 1) in bovine adipocytes. EMSA and siRNA interference confirmed PLAG1 binding to its consensus site in the PLIN1 core promoter (-209/-17 bp), and PLAG1 knockdown reduced PLIN1-driven luciferase activity and impaired lipid metabolism in adipocytes.\",\n      \"method\": \"Promoter cloning and luciferase assay, EMSA, siRNA knockdown, mutational analysis of promoter fragments\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA and functional luciferase assay with siRNA KD, single lab in bovine model\",\n      \"pmids\": [\"31981700\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PLAG1 is a developmentally regulated C2H2 zinc finger transcription factor that binds a bipartite DNA consensus sequence (GRGGC[N6–8]GGG) via zinc fingers 3, 6, and 7 to transactivate target genes including IGF2 (P3 promoter), GPX4, BCL2, MSI2, GDH1, and PLIN1; it is imported into the nucleus via karyopherin alpha2/NLS1; its transcriptional activity is repressed by SUMOylation at Lys-244/Lys-263 and activated by p300-mediated acetylation/reversed by HDAC7; in cancer and normal development it is frequently overexpressed via promoter-swapping gene fusions (CTNNB1-, CHCHD7-, TCEA1-, FGFR1-, LIFR-, HAS2-, COL1A2-PLAG1 and others) or by upstream HMGA2 transcriptional activation; functionally, PLAG1 drives cell proliferation and survival through IGF2-mTORC1 and PI3K-AKT signaling, promotes HSC dormancy and self-renewal by dampening protein synthesis via 4EBP1 and miR-127, supports spermatogenesis, and cooperates with CBFbeta-SMMHC to induce AML.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PLAG1 is a developmentally regulated, DNA-binding transcription factor that controls cell proliferation, survival, and organismal growth by activating target gene programs centered on insulin-like growth factor signaling [#0, #8, #18]. It binds a bipartite consensus sequence (GRGGC core plus a downstream G-cluster separated by ~6\\u20138 nucleotides) through zinc fingers 3, 6, and 7, and uses this activity to transactivate the IGF2/IGF-II P3 promoter and other targets enriched for the same motif [#0, #6]. Nuclear function depends on karyopherin alpha2-mediated import via the NLS1 (KRKR) sequence, and transcriptional output is set by competing post-translational modifications\\u2014SUMOylation at Lys-244/Lys-263/Lys-353 represses activity (and mislocalizes the protein to the nucleolus when lost), while p300-mediated acetylation activates it and HDAC7 reverses this [#3, #4, #5]. A recurrent theme across normal and malignant tissues is PLAG1 dysregulation: in pleomorphic adenoma, lipoblastoma, and related tumors it is ectopically overexpressed through promoter-swapping fusions that place its coding sequence under constitutively active partner promoters (CTNNB1, TCEA1, CHCHD7, FGFR1, HAS2, COL1A2), and it is also activated downstream of HMGA2 or derepressed by loss of inhibitory microRNAs [#1, #2, #11, #14, #19, #15]. Functionally, PLAG1 drives growth through IGF2-dependent activation of AKT/MAPK and mTORC1 signaling, reinforces survival by transcribing BCL2 and the ferroptosis suppressor GPX4, and mediates metabolic adaptation via GDH1; genetic models show it is required for postnatal growth, spermatogenesis, neocortical progenitor balance, and cooperates with CBFbeta-SMMHC to induce acute myeloid leukemia [#22, #23, #28, #17, #8, #20, #30, #7]. In human hematopoietic stem cells PLAG1 promotes self-renewal by restraining protein synthesis through 4EBP1 and miR-127 and co-activates MSI2 with USF2 [#24, #21]. Loss-of-function PLAG1 mutations cause Silver-Russell syndrome with fetal growth restriction [#18].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Established PLAG1's core molecular identity by defining its sequence-specific DNA-binding mode and its first direct target, answering how an oncogenic transcription factor engages chromatin.\",\n      \"evidence\": \"In vitro DNA-binding and zinc-finger mutagenesis with transactivation reporters and IGF-II P3 promoter binding\",\n      \"pmids\": [\"10646861\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide binding repertoire not yet defined\", \"Cofactor requirements for transactivation unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Showed that PLAG1 oncogenicity arises chiefly from deregulated expression rather than coding mutation, by identifying promoter-swapping fusions that drive ectopic expression across distinct tumor types.\",\n      \"evidence\": \"5'-RACE, RT-PCR, sequencing of fusion transcripts in pleomorphic adenoma and lipoblastoma (CTNNB1, TCEA1, HAS2, COL1A2)\",\n      \"pmids\": [\"10029085\", \"10987300\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether overexpression alone is sufficient for transformation not addressed\", \"Downstream effector program not mapped\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Defined how PLAG1 reaches the nucleus, identifying the NLS1 element and its import receptor required for function.\",\n      \"evidence\": \"Yeast two-hybrid, GST pull-down, NLS mutagenesis, and nuclear import reporter assays\",\n      \"pmids\": [\"11882654\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Regulation of import in different cell states unknown\", \"Contribution of zinc-finger-mediated residual import not quantified\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Resolved how PLAG1 transcriptional output is tuned, showing opposing control by repressive SUMOylation and activating p300 acetylation/HDAC7 deacetylation, linking modification state to subcellular localization and transforming capacity.\",\n      \"evidence\": \"In vivo SUMOylation and acetylation assays, lysine mutagenesis, localization, and transformation assays\",\n      \"pmids\": [\"15208321\", \"16207715\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signals controlling the SUMO/acetyl switch unknown\", \"SUMO ligases acting on PLAG1 not identified\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Defined the PLAG1 target gene program genome-wide and confirmed motif-driven regulation, anchoring IGF-II as a principal output.\",\n      \"evidence\": \"Oligonucleotide microarray on conditional PLAG1 cells with in silico promoter motif analysis and tumor-profile concordance\",\n      \"pmids\": [\"14712223\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect targets not separated by binding data\", \"Restricted to one cell context\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Provided direct in vivo proof that PLAG1 overexpression is tumorigenic and activates imprinted growth loci, moving beyond correlative fusion data.\",\n      \"evidence\": \"Cre/loxP conditional PLAG1 transgenic mice with histopathology and Igf2/H19, Dlk1/Gtl2 expression analysis\",\n      \"pmids\": [\"15930271\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of imprinted cluster activation unresolved\", \"Cell-of-origin contributions not dissected\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Tested the causal weight of IGF2 in PLAG1 tumorigenesis, revealing IGF2 is important but not solely responsible and implicating parallel Wnt signaling.\",\n      \"evidence\": \"Genetic epistasis (Igf2 inactivation on PLAG1-transgenic background) with tumor latency and target gene profiling\",\n      \"pmids\": [\"18425330\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of Wnt vs residual IGF signaling unquantified\", \"Direct PLAG1 regulation of human Wnt targets unproven\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Defined PLAG1's physiological roles and IGF2-independent functions using a clean knockout, distinguishing developmental requirement from its canonical IGF2 axis.\",\n      \"evidence\": \"Targeted Plag1 disruption in mice with growth, organ-weight, and Igf2 expression analysis; AML cooperation model with CBFbeta-SMMHC\",\n      \"pmids\": [\"15606491\", \"15585652\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of Igf2-independent growth effectors unknown\", \"Tissue-specific target programs not defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showed PLAG1 is controlled post-transcriptionally, with microRNA loss derepressing PLAG1 protein independent of mRNA level, expanding the routes to its overexpression in cancer.\",\n      \"evidence\": \"miRNA profiling, 3'UTR luciferase reporters with mutagenesis, Western blot, and miRNA promoter methylation analysis in CLL\",\n      \"pmids\": [\"19692702\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PLAG1 derepression is driver or passenger in CLL not established\", \"Downstream consequences in B cells not defined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Placed PLAG1 downstream of HMGA2, establishing an HMGA2-PLAG1-IGF2 axis that explains PLAG1 activation in tumors lacking chromosome 8 rearrangements.\",\n      \"evidence\": \"HMGA2 and FGF1 stimulation with qRT-PCR in MCF-7 and stem cells, plus leiomyoma correlation; later WES of Silver-Russell families with functional pathway validation\",\n      \"pmids\": [\"24516594\", \"28796236\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct HMGA2 binding at the PLAG1 locus not shown\", \"Mechanism of HMGA2-driven PLAG1 transcription unresolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Broadened PLAG1 effector biology beyond growth, demonstrating metabolic (GDH1/AMPK anti-anoikis) and developmental (spermatogenesis) functions through distinct target genes.\",\n      \"evidence\": \"Knockdown/overexpression, co-IP, metabolic assays and PDX for GDH1; Plag1 knockout testis RNA-seq and sperm phenotyping\",\n      \"pmids\": [\"29249655\", \"28706261\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct PLAG1 binding at GDH1 and spermatogenesis loci not all confirmed\", \"Context-specificity of metabolic axis unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Established PLAG1 as a regulator of stem/progenitor identity, mapping genome-wide occupancy and cooperative MSI2 activation with USF2 and a tumorigenic role in Wilms tumor via IGF2-mTORC1.\",\n      \"evidence\": \"ChIP-seq, reporter assays, cord blood and Wilms tumor in vitro/in vivo growth models\",\n      \"pmids\": [\"29641991\", \"30026293\", \"30361413\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Determinants of PLAG1-USF2 cooperativity not defined\", \"How the same factor expands progenitors yet restrains self-renewal elsewhere unresolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Connected PLAG1 to therapy resistance, showing transcriptional activation of survival/anti-ferroptosis genes (GPX4, BCL2) that modulate response to apoptotic and ferroptotic drugs.\",\n      \"evidence\": \"ChIP and luciferase reporter for GPX4/BCL2 promoters, knockdown with drug-sensitivity assays in HCC and AML; bovine myoblast/adipocyte PI3K-Akt and PLIN1 studies\",\n      \"pmids\": [\"38745179\", \"27013583\", \"35325183\", \"31981700\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Generality of the resistance phenotype across tumor types unproven\", \"Direct binding confirmed for some but not all survival targets\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Defined a translational-control mechanism for PLAG1 in human HSCs, showing it dampens protein synthesis via 4EBP1 and miR-127 to enforce self-renewal, opposed by c-MYC.\",\n      \"evidence\": \"Genome-wide ChIP occupancy, RNA-seq, HSC functional assays, protein synthesis measurement, and c-MYC epistasis\",\n      \"pmids\": [\"35639948\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How PLAG1 toggles between pro-proliferative and translation-restraining programs unknown\", \"Direct vs indirect regulation of 4EBP1/miR-127 not fully separated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"What determines whether PLAG1 acts as a growth-promoting oncogene versus a self-renewal-enforcing, translation-restraining regulator in a given cell remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking modification state, cofactor availability (USF2), and context-specific target selection\", \"Structural basis of bipartite DNA recognition not solved\", \"Mechanism by which the same factor restrains vs promotes proliferation not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 6, 21, 22, 23, 28, 32]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 6, 32]},\n      {\"term_id\": \"GO:0003700\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 6, 21, 22]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [17, 22, 27]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [8, 20, 30]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [1, 2, 7, 22, 28]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [23, 28]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"KPNA2\", \"USF2\", \"EP300\", \"HDAC7\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}